Clinical insignificance of [18F]PSMA-1007 avid non-specific bone lesions: a retrospective evaluation

Conclusion[18F]PSMA-1007 avid NSBLs rarely represent prostate cancer bone metastases. When identified in the absence of definite metastatic disease elsewhere, it is appropriate to classify those with SUVmax  <  7.2 as likely benign. NSBLs with SUVmax 7.2–11.1 may be classified as equivocal or metastatic, with patient clinical risk factors, scan appearance, and potential management implications used to guide interpretation.
Source: European Journal of Nuclear Medicine and Molecular Imaging - Category: Nuclear Medicine Source Type: research